What we do ANG Lifesciences India Ltd manufactures and markets pharmaceutical formulations including sterile dry powder injections and diversified dosage forms, serving hospitals and doctors primarily in India. |
Founded in 2,006 |
Market share Strong presence in India's pharmaceutical injections market with diversified dosage forms; operates four manufacturing plants with ISO and GMP certifications. |
Problem solved Provides high-quality injectable and oral pharmaceutical products ensuring cost-effective treatment options for healthcare providers. |
Top clients or who we serve B2B focus: Indian hospitals, doctors, and healthcare providers via stockists; growing presence in pharmaceutical packaging for backward integration. |
Key management Rajesh Gupta (Managing Director), Saruchi Gupta (Whole-time Director & CFO) |
Our journey and innovations Started commercial production in 2008-09, direct sales in 2014-15, and acquired pharma packaging firm in 2021 for supply chain efficiency. |
Where we operate Primarily India with minor exports internationally. |
Top products or what we offer Sterile dry powder injection vials, tablets, capsules, liquid syrups, liquid injections (ampoules/vials), pre-filled syringes. |
Top brands Not specified distinct brands; flagship offerings include Beta Lactum and Non-Beta Lactum formulations. |
Raw materials needed Active pharmaceutical ingredients, packaging materials for injections and oral formulations. |
Raw materials supplier Not specified. |
Recurring vs cyclical contribution Revenue primarily from recurring pharmaceutical sales with some cyclical impacts due to regulatory environment. |
Our industry position Mid-sized player with niche in sterile injectable formulations and integrated pharma packaging services. |
Financial highlights FY 2024-25 revenue around Rs. 92.85 crore with net loss of Rs. 12.41 crore reflecting ongoing investments and industry challenges. |
Geographical revenue split Within India 84.86 crore; Outside India 5.05 crore in FY 2024-25. |
Order book - |
Whats driving growth Demand from healthcare sector, backward integration via packaging acquisition, and product diversification. |
Our future plans Focus on capacity expansion, cost optimization through packaging integration, and strengthening domestic market share. |
Our green promise Committed to environmental regulations and safety with energy conservation initiatives at manufacturing units. |
Our people and values Cordial industrial relations fostering employee dedication; emphasis on compliance and ethical operations. |
Key challenges ahead Financial losses, regulatory compliance delays, and managing competitive pressure in pharmaceutical manufacturing. |
Interesting facts Converted multiple times between private and public limited status; acquired a packaging company to reduce costs and ensure material availability. |
Risks and strategy Mitigates risks through internal financial controls, vigilant monitoring of compliance, and diversification of products and operations. |
